reviveprocare.com (AXIL) Company Long-Term Loans and Borrowings

AXIL Brands - graphic logo of issuer AXIL

The market valuation dynamics for AXIL Brands, Inc. (AXIL) reflect a value of 0.00, prompting the company to scale its premium skin and hair care assortment through online sales and the expansion of its retail presence. The business generates revenue from therapeutic cosmetics and hearing protection for shooters and patients. Success is driven by electronics brand recognition, high-quality design, and an extensive network of specialized stores.

AXIL AXIL Brands Inc: Company Long-Term Debts in the range 02/21/2024 - 10/28/2026

Analytical breakdowns for AXIL Brands (AXIL)

- price and consensus price forecast:
Stock Price AXIL Brands Inc|AXIL - Price Target Chart
- market capitalization data:
Market Value AXIL Brands|AXIL - Total Company Value
- book capitalization data:
Accounting Value per Share AXIL Brands|AXIL - Book Capitalization|Market Capitalization to Book Value Ratio reviveprocare.com|AXIL - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio AXIL Brands, Inc.|AXIL - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient AXIL Brands Inc|AXIL - Company Debts|Debts to Book Capitalization AXIL Brands|AXIL - Company Long-Term Debts|Short-Term Debt Volume AXIL Brands
Summary company analytics:AXIL (AXIL Brands, Inc.)
Manufactured products of AXIL Brands, Inc.

Long-term debt reflects the aggregate of credit obligations with a maturity of more than one year, measuring the sustainability of financial leverage and the risk of default upon a breach of covenants. Analyzing the issuer's long-term liabilities reveals whether AXIL Brands, Inc. (AXIL) is utilizing borrowed funds to finance its premium staff of trichologists and marketers to maintain brand aesthetics and the employee bonus system.

Competing companies

krystalbio.com - Company Long-Term Debts|Company Long-Term Debt Apogee Therapeutics, Inc. (APGE)|ARQT: Company Long-Term Loans and Borrowings|VCEL (Vericel Corp.) - Company Long-Term Debt|Oruka Pharma (ORKA) - Company Long-Term Liabilities|SMTI (Sanara MedTech, Inc.) - Company Long-Term Debts|Company Long-Term Debts DBV Technologies SA (DBVT)|Solesence Inc (SLSN) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings DERM (journeymedicalcorp.com)|Company Long-Term Debt FBRX|Empro Corporation - Long-Term Debt Volume|Sol-Gel Technologies - Company Long-Term Debt|MDCX - Company Long-Term Debts|verrica.com - Company Long-Term Debts|HOTH (Hoth Therapeutics) - Long-Term Debt Volume|Company Long-Term Debt Biofrontera, Inc. (BFRI)|Company Long-Term Indebtedness VYNE Therapeutics Inc|Company Long-Term Debts SNOA|Company Long-Term Debts quoinpharma.com QNRX|AZTR - Company Long-Term Liabilities|Company Long-Term Indebtedness Dermata Therapeutics Inc DRMA|Company Long-Term Debts ELAB (Elevai Skincare)|RVNC: Long-Term Debt Volume